Berkeley, California
United States
81
2025-06-19
The entities that hold a legal rights for patent applications filed by inventor Spevak Wayne:
Wayne Spevak from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#2 | 2024-05-30COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#3 | 2024-05-30Compounds and methods for CD73 modulation and indications therefor
#4 | 2023-09-07Compounds and methods for kinase modulation, and indications therefor
#5 | 2023-03-16COMPOUNDS AND METHODS FOR KRAS MODULATION AND INDICATIONS THEREFOR
#6 | 2022-11-10Heterocyclic compounds and uses thereof
#7 | 2022-05-12Compounds and methods for CD73 modulation and indications therefor
#8 | 2021-11-18COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#9 | 2021-11-11COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#10 | 2021-10-14Compounds and methods for EP300 or CBP modulation and indications therefor
#11 | 2021-10-14COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR
#12 | 2021-07-01COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR
#13 | 2020-10-29Heterocyclic compounds and uses thereof
#14 | 2019-12-05Heterocyclic compounds and uses thereof
#15 | 2019-10-03Compounds and methods for IDO and TDO modulation, and indications therefor
#16 | 2019-07-11COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#17 | 2019-06-13Compounds and methods for kinase modulation, and indications therefor
#18 | 2018-12-13Compounds and methods for kinase modulation
#19 | 2018-11-15Heterocyclic compounds and uses thereof
#20 | 2018-08-02Compounds and methods for CDK8 modulation and indications therefor
#21 | 2018-04-26COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#22 | 2018-04-12Compounds for kinase modulation, and indications therefor
#23 | 2018-04-12Compounds and methods for IDO and TDO modulation, and indications therefor
#24 | 2018-03-15Heterocyclic compounds and uses thereof
#25 | 2018-01-04Synthesis of heterocyclic compounds
#26 | 2017-12-21Heterocyclic compounds and uses thereof
#27 | 2017-12-07Compounds and methods for kinase modulation, and indications therefor
#28 | 2017-11-09Heterocyclic compounds and uses thereof
#29 | 2017-11-09COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#30 | 2017-10-05COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#31 | 2017-09-21Compounds and methods for kinase modulation, and indications therefor
#32 | 2017-06-08Compounds and methods for kinase modulation, and indications therefor
#33 | 2017-06-08Compounds and methods for kinase modulation, and indications therefor
#34 | 2017-03-23Heterocyclic compounds and uses thereof
#35 | 2017-03-02Compounds and methods for kinase modulation, and indications therefor
#36 | 2016-11-24Synthesis of heterocyclic compounds
#37 | 2016-11-24Kinase modulation, and indications therefor
#38 | 2016-11-10Compounds and methods for kinase modulation, and indications therefor
#39 | 2016-06-23COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#40 | 2016-06-16Compounds and methods for kinase modulation, and indications therefor
#41 | 2016-03-17Heterocyclic compounds and uses thereof
#42 | 2016-03-10Heterocyclic compounds and uses thereof
#43 | 2015-10-15COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#44 | 2015-10-08Compounds and methods for kinase modulation, and indications therefor
#45 | 2015-07-02Compounds and methods for kinase modulation, and indications therefor
#46 | 2015-05-14Heterocyclic compounds and uses thereof
#47 | 2015-03-19Compounds and methods for kinase modulation, and indications therefor
#48 | 2014-12-04Compounds for kinase modulation, and indications therefor
#49 | 2014-10-09COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#50 | 2014-10-09HETEROCYCLIC COMPOUNDS AND USES THEREOF
#51 | 2014-09-25Compounds and methods for kinase modulation, and indications therefor
#52 | 2014-07-31Compounds and methods for kinase modulation, and indications therefor
#53 | 2014-05-08Compounds and methods for kinase modulation, and indications therefor
#54 | 2014-05-08Compounds and methods for kinase modulation, and indications therefor
#55 | 2014-02-13Compounds and methods for kinase modulation, and indications therefor
#56 | 2014-02-06COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#57 | 2013-11-14COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#58 | 2013-10-03COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#59 | 2013-09-12COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#60 | 2012-09-27COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#61 | 2012-06-28COMPOUNDS AND USES THEREOF
#62 | 2012-05-17SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS
#63 | 2012-03-01COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#64 | 2011-10-27Compounds and methods for kinase modulation, and indications therefor
#65 | 2011-07-28COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#66 | 2011-07-07COMPOUNDS MODULATING C-KIT AND C-FMS ACTIVITY AND USES THEREFOR
#67 | 2011-06-23Compounds and methods for kinase modulation, and indications therefor
#68 | 2011-05-12COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#69 | 2011-04-21COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#70 | 2011-03-10Compounds and methods for kinase modulation, and indications therefor
#71 | 2010-11-11Pyrrolo[2,3-]pyridine kinase inhibitors
#72 | 2010-11-11Compounds and methods for kinase modulation, and indications therefor
#73 | 2010-10-07Compounds and methods for kinase modulation, and indications therefor
#74 | 2010-09-30Compounds and methods for kinase modulation, and indications therefor
#75 | 2010-09-16Compounds and uses thereof
#76 | 2010-07-29COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#77 | 2009-12-10Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
#78 | 2009-11-19Compounds and methods for kinase modulation, and indications therefor
#79 | 2008-08-07Compounds and methods for kinase modulation, and indications therefor
#80 | 2008-07-10Compounds and methods for kinase modulation, and indications therefor
#81 | 2007-02-08Compounds modulating c-kit and c-fms activity and uses therefor
434757 ⎘